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A Commentary on
Commentary: Reducing Viability Bias in Analysis of GutMicrobiota in Preterm Infants at Risk
of NEC and Sepsis
by Agustí, G., and Codony, F. (2018). Front. Cell. Infect. Microbiol. 8:212.
doi: 10.3389/fcimb.2018.00212
We would like to thank Agustí and Codony (2018), for their interest in our recent manuscript
(Young et al., 2017), and valuable comments. We agree that non-viable cell exclusion is an
important consideration, worth making when conducting analyses of microbial communities via
targeted DNA sequencing and amplification approaches. The technique is especially pertinent in
environments where large volumes of non-viable bacteria are expected, such as in preterm infant
stool, where multiple clinical interventions manifest deliberate bacterial killing.
Whilst we agree with the general principles with regards to sample collection and handling
described by Agustí and Codony (2018) we maintain that these are not always possible in real-life,
clinical patient samples. For example, as patient care is the primary concern in this cohort, sample
collection is convenience based rather than experimentally dictated. This requires samples to be
spontaneously collected and stored prior to processing. We concede this increases the likelihood
of loss of anaerobic bacterial viability. We would, however point out that the study by Brusa et al.
(1989), highlighted in the commentary defines viability purely as culturability. Studies (Contreras
et al., 2011; Nocker et al., 2011) have reported loss of culturability occurs at lower stress levels
than loss of membrane integrity. Thus, suggesting greater cellular stress may be required to deplete
DNA signals from non-viable cells, as determined during PMA-based viability assays. Moreover,
we highlight in our manuscript that PMA is a conservative parameter for loss of viability. We
also propose that, in the specific cohort investigated, conservative non-viable determination is
preferable to over-exaggerated determination or a complete absence of it. This is especially true
when non-treated samples can be analyzed in parallel.
DNA retention on microtube surfaces and subsequent inclusion in the viable communities may
well be an issue in PMA-based viability determination. In our study however, samples were not
heat-killed at any point. This is in contrast to the study by Agustí et al. (2017), in which DNA
binding to microtube walls may have occurred prior to PMA-treatment. Furthermore, the methods
Young et al. Response: Reducing vPCR Bias
described by ourselves outline transfer between sterile glass pots
during initial sample collection and several microtubes and well
plates from PMA-addition to incubation and photo-activation
and, finally DNA isolation. We propose that these several steps
are sufficient to reduce the impact of DNA retained onmicrotube
surfaces on the assigned live DNA fraction.
In addition to the valuable comments made by Agustí
and Codony (2018), where the target sequence is <300
bp we recommend combination of a nested-PCR approach,
comprising initial long fragment pre-amplification, followed
by subsequent target amplicon sequencing/quantification, first
described by Luo et al. (2010). This increases the likelihood of
encountering intercalated PMA during the DNA amplification
process.
The use of PMA as a viability-dye is extremely useful in
microbial community analysis. As a greater volume of literature
becomes available regarding it’s use, the technique will no doubt
refine. From our experience with the technique, we propose
several important considerations to be made when planning any
study in which PMA-based non-viable cell exclusion is employed:
• Is the sample likely to contain substantial volumes of DNA
originating from non-viable bacteria?
• Are the collection and storage methods likely to impact
community viability?
• What is the composition of the sample? (Homogenisation
may be required)
• What is the optimal concentration of PMA required to ensure
non-viable cell DNA quenching?
• Is there potential for extra-cellular DNA carry-over in the
methods? (specifically fromDNA retained on plastics surfaces)
• What is my light-source for photoactivation (464 nm is
excitation maxima of PMA therefore substantial emission at
this wavelength is required)
• Can I employ a nested-PCR approach tomaximize intercalated
PMA impact?
• Can I afford to sequence the non-treated sample also?
(Particularly useful in clinical environments to ID bacterial
communities that may have been viable recently)
• Can I afford to supplement this technique with another
to confirm presence/viability? (e.g., FISH, flow cytometry,
selective culture)
We would further direct anyone interested to a comprehensive
review of the technique by Fittipaldi et al. (2012).
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